Life Sciences News @ Gowlings

November 18, 2009

Use Twitter? Follow Gowlings news on Twitter

Genzyme to stop development of phosphate binder
http://www.reuters.com/article/rbssHealthcareNews/idUSBNG110820091118

Roche announces late-stage trial for heart drug
http://www.reuters.com/article/rbssHealthcareNews/idUSLI3323220091118

NicOx in fund raising to speed naproxcinod launch
http://www.reuters.com/article/rbssHealthcareNews/idUSLI3966520091118

Pfizer taking more targeted approach to R&D
http://www.pharmatimes.com/WorldNews/article.aspx?id=16930

Crestor halves CV risk in relatively-healthy women
http://www.pharmatimes.com/WorldNews/article.aspx?id=16929

FDA says PPIs reduce effectiveness of Plavix
http://www.pharmatimes.com/WorldNews/article.aspx?id=16927

A Genetics Company Fails, Its Research Too Complex
http://www.nytimes.com/2009/11/18/business/18gene.html?_r=1&ref=health

Biotech Cosmo aims to buy rival BioXell for $41 mln
http://www.reuters.com/article/swissMktRpt/idUSLI5841420091118

Irish food could be marketed as 'GM-free'
http://www.irishtimes.com/newspaper/ireland/2009/1118/1224259044847.html

Dr. Donald Rix was a giant in life sciences
http://www.timescolonist.com/business/giant+life+sciences/2236057/story.html

Unfriend - word of the year
http://www.ananova.com/news/story/sm_3567011.html?menu

Life Sciences News @ Gowlings is a daily news service that provides news items of interest to those in the life sciences.

If you wish to subscribe/unsubscribe to any Gowlings newsletter, please visit http://www.gowlings.com/e-form/subscribe.asp and complete our subscription form. By your use of this service you agree to the Terms and Conditions set out at http://www.gowlings.com/resources/newsletterList.asp?intNewsletterTypeId=99. If you do not agree with the Terms and Conditions, please do not use the service.

Please contact LifeSciencesNews@gowlingsnewsletters.com with questions or comments.

Gowlings and Personal Information - Gowlings respects your privacy. Please see Gowlings' Privacy Policy for more information about how our Firm manages your personal information.

Gowlings is an acknowledged leader in business law, technology law, intellectual property and advocacy.